Cytotoxicity of Biologically Synthesised Bismuth Nanoparticles Against HT-29 Cell Line

Overview

Journal IET Nanobiotechnol

Publisher Wiley

Specialty Biotechnology

Date 2018 Aug 11

PMID 30095428

Citations 6

Authors

Mojtaba Shakibaie

Hamid Forootanfar

Atefeh Ameri

Mahboubeh Adeli-Sardou

Mandana Jafari

Hamid Reza Rahimi

Affiliations

Soon will be listed here.

Abstract

This study was purposed to examine the cytotoxicity and functions of biologically synthesised bismuth nanoparticles (Bi NPs) produced by sp. SFG on human colon adenocarcinoma cell line of HT-29. The structural properties of Bi NPs were investigated using transmission electron microscopy, energy dispersive X-ray, and X-ray diffraction techniques. The cytotoxic effects of Bi NPs were analysed using flow cytometry cell apoptosis while western blot analyses were applied to analyse the cleaved caspase-3 expression. Oxidative stress (OS) damage was determined using the measurement of the glutathione (GSH) and malondialdehyde (MDA) levels and antioxidant activity of superoxide dismutase (SOD) and catalase (CAT) levels. The half maximal inhibitory concentration (IC) value of Bi NPs was measured to be 28.7 ± 1.4 µg/ml on HT-29 cell line. The viability of HT-29 represented a concentration-dependent pattern (5-80 µg/ml). The mode of Bi NPs induced apoptosis was found to be mainly related to late apoptosis or necrosis at IC concentration, without the effect on caspase-3 activities. Furthermore, Bi NPs reduced the GSH and increased the MDA levels and decreased the SOD and CAT activities. Taken together, biogenic Bi NPs induced cytotoxicity on HT-29 cell line through the activation of late apoptosis independent of caspase pathway and may enhance the OS biomarkers.

Citing Articles

Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion.

Chan P, Ang K, Hamid R J Biol Inorg Chem. 2024; 29(2):217-241.

PMID: 38369679 DOI: 10.1007/s00775-023-02041-x.

Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?.

Goncalves A, Matias M, Salvador J, Silvestre S Int J Mol Sci. 2024; 25(3).

PMID: 38338879 PMC: 10855265. DOI: 10.3390/ijms25031600.

Microenvironmental Behaviour of Nanotheranostic Systems for Controlled Oxidative Stress and Cancer Treatment.

Rehman Y, Qutaish H, Kim J, Huang X, Alvi S, Konstantinov K Nanomaterials (Basel). 2022; 12(14).

PMID: 35889688 PMC: 9319169. DOI: 10.3390/nano12142462.

Medical Applications of Metallic Bismuth Nanoparticles.

Gomez C, Hallot G, Laurent S, Port M Pharmaceutics. 2021; 13(11).

PMID: 34834207 PMC: 8624144. DOI: 10.3390/pharmaceutics13111793.

Synergetic Influence of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-Rich Fraction on Reactive Oxygen Species Generation and Radiosensitization Effects for Clinical Radiotherapy Beams.

Talik Sisin N, Razak K, Abidin S, Che Mat N, Abdullah R, Ab Rashid R Int J Nanomedicine. 2020; 15:7805-7823.

PMID: 33116502 PMC: 7567565. DOI: 10.2147/IJN.S269214.

References

Beil W, Bierbaum S, SEWING K . Studies on the mechanism of action of colloidal bismuth subcitrate. I. Interaction with sulfhydryls. Pharmacology. 1993; 47(2):135-40. DOI: 10.1159/000139088. View

Bagchi D, Carryl O, Tran M, Bagchi M, Vuchetich P, Krohn R . Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts. Dig Dis Sci. 1997; 42(9):1890-900. DOI: 10.1023/a:1018811210175. View

Xie J, Cao Y, Jia D, Li Y . Dahlia-shaped BiOClI structures prepared by a facile solid-state method: Evidence and mechanism of improved photocatalytic degradation of rhodamine B dye. J Colloid Interface Sci. 2017; 503:115-123. DOI: 10.1016/j.jcis.2017.05.016. View

Forootanfar H, Amirpour-Rostami S, Jafari M, Forootanfar A, Yousefizadeh Z, Shakibaie M . Microbial-assisted synthesis and evaluation the cytotoxic effect of tellurium nanorods. Mater Sci Eng C Mater Biol Appl. 2015; 49:183-189. DOI: 10.1016/j.msec.2014.12.078. View

Shakibaie M, Forootanfar H, Golkari Y, Mohammadi-Khorsand T, Shakibaie M . Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J Trace Elem Med Biol. 2014; 29:235-41. DOI: 10.1016/j.jtemb.2014.07.020. View

Ouyang R, Yang Y, Tong X, Feng K, Yang Y, Tao H . Potent anticancer activity of a new bismuth (III) complex against human lung cancer cells. J Inorg Biochem. 2016; 168:18-26. DOI: 10.1016/j.jinorgbio.2016.12.006. View

Patterson D, Vilensky J, Robertson W, Berger J . Treatment and diagnostic accuracy of neurosyphilis at Boston City Hospital's Neurological Unit, 1930-1979. J Neurol Sci. 2011; 314(1-2):1-4. DOI: 10.1016/j.jns.2011.11.007. View

Stoltenberg M, Larsen A, Zhao M, Danscher G, Brunk U . Bismuth-induced lysosomal rupture in J774 cells. APMIS. 2002; 110(5):396-402. DOI: 10.1034/j.1600-0463.2002.100505.x. View

Sundar S, Chakravarty J . Antimony toxicity. Int J Environ Res Public Health. 2011; 7(12):4267-77. PMC: 3037053. DOI: 10.3390/ijerph7124267. View

10.

Chang Y, Cheng T, Yang X, Jin L, Sun H, Li H . Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival. J Biol Inorg Chem. 2017; 22(5):673-683. DOI: 10.1007/s00775-017-1452-5. View

11.

Pathak A, Blair V, Ferrero R, Kedzierski L, Andrews P . Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania. J Inorg Biochem. 2017; 177:266-275. DOI: 10.1016/j.jinorgbio.2017.05.014. View

12.

Levantine A, Almeyda J . Drug induced changes in pigmentation. Br J Dermatol. 1973; 89(1):105-12. DOI: 10.1111/j.1365-2133.1973.tb01932.x. View

13.

de Andrade Luz L, Rossato F, Pereira E Costa R, Napoleao T, Paiva P, Coelho L . Cytotoxicity of the coagulant Moringa oleifera lectin (cMoL) to B16-F10 melanoma cells. Toxicol In Vitro. 2017; 44:94-99. DOI: 10.1016/j.tiv.2017.06.019. View

14.

Liu Y, Zhuang J, Zhang X, Yue C, Zhu N, Yang L . Autophagy associated cytotoxicity and cellular uptake mechanisms of bismuth nanoparticles in human kidney cells. Toxicol Lett. 2017; 275:39-48. DOI: 10.1016/j.toxlet.2017.04.014. View

15.

Abudayyak M, Oztas E, Arici M, Ozhan G . Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines. Chemosphere. 2016; 169:117-123. DOI: 10.1016/j.chemosphere.2016.11.018. View

16.

Rahimi H, Ghahremani M, Dehpour A, Sharifzadeh M, Ejtemaei-Mehr S, Razmi A . The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of Rat. Iran J Pharm Res. 2015; 14(4):1123-35. PMC: 4673940. View

17.

Liman R . Genotoxic effects of Bismuth (III) oxide nanoparticles by Allium and Comet assay. Chemosphere. 2013; 93(2):269-73. DOI: 10.1016/j.chemosphere.2013.04.076. View

18.

Ovaska H, Wood D, House I, Dargan P, Jones A, Murray S . Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation. Clin Toxicol (Phila). 2008; 46(9):855-7. DOI: 10.1080/15563650801953182. View

19.

Li Z, Liu J, Hu Y, Li Z, Fan X, Sun Y . Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors. Biomaterials. 2017; 141:284-295. DOI: 10.1016/j.biomaterials.2017.06.033. View

20.

Friesen C, Roscher M, Hormann I, Leib O, Marx S, Moreno J . Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked.... Eur J Cancer. 2013; 49(11):2542-54. DOI: 10.1016/j.ejca.2013.04.008. View